WAYNE, Pa. (AP) — WAYNE, Pa. (AP) — Aclaris Therapeutics Inc. (ACRS) on Thursday reported a loss of $19.8 million in its fourth quarter.
The Wayne, Pennsylvania-based company said it had a loss of 16 cents per share.
The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 15 cents per share.
The specialty pharmaceutical company posted revenue of $1.3 million in the period, which also missed Street forecasts. Five analysts surveyed by Zacks expected $1.9 million.
For the year, the company reported that its loss narrowed to $64.9 million, or 53 cents per share. Revenue was reported as $7.8 million.
The company’s shares closed at $3.31. A year ago, they were trading at $2.06.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACRS at https://www.zacks.com/ap/ACRS
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
